Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Research suggests it encourages the breakdown of stored fat without significantly affecting blood sugar or acting through the IGF-1 pathway
Insurance coverage for BPC-157 remains limited in 2026, with most patients paying out-of-pocket for treatment
used to monitor warfarin therapy
short sequential cohort about -4.7% during the initial 2.5 mg phase and -12.7% by the end of the 5 mg phase (Barrea EXCLI Journal 2026)
The initial weight loss often includes water weight as tirzepatide reduces food intake and begins altering metabolic function
The peptide protects gastric mucosa from damage induced by NSAIDs (non-steroidal anti-inflammatory drugs), alcohol, and stress, counteracting the pathological effects of these ulcerogenic agents
US$ 29.75
US$ 28.90
US$ 28.73
